Dapagliflozin Mitigates Hypotension in Lipopolysaccharide-Induced Acute Inflammation Independent of Glycemia Level
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been suggested to have anti-inflammatory properties in diabetes. The goal of this study was to evaluate the role of the SGLT2 inhibitor dapagliflozin (DAPA) in the attenuation of lipopolysaccharide (LPS)-induced hypotension. Male Wistar albino r...
Saved in:
Main Authors: | Wael A. Alanazi (Author), Turki Alharbi (Author), Doaa M. El-Nagar (Author), Abdullah M. Albogami (Author), Mohammed Alswayyed (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dapagliflozin/Hesperidin Combination Mitigates Lipopolysaccharide-Induced Alzheimer's Disease in Rats
by: Maaly A. Abd Elmaaboud, et al.
Published: (2023) -
Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently
by: Sato N, et al.
Published: (2019) -
Mechanism Underlying Triple VEGFR Inhibitor Tivozanib-Induced Hypertension in Mice Model
by: Wael A. Alanazi, et al.
Published: (2023) -
The effect of inhibiting hindbrain A2 noradrenergic neurons by 6-Hydroxydopamine on lipopolysaccharide-treated male rats autistic animal model
by: Hussain N. Alhamami, et al.
Published: (2024) -
The Impact of Biofeedback on Diabetic Patients' Glycemia
by: Fariba Aaraji, et al.
Published: (2018)